General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Novartis & Citizenship

June 23, 2010

As one of the first signatories of the United Nations Global Compact, we fully support its efforts to improve human rights, labor standards, the environment and efforts to combat corruption. The Global Compact has become the cornerstone of Corporate Citizenship at Novartis – an integral part of how we operate, and a key to our success. Our commitment to Corporate Citizenship rests on four pillars:

  • patients
  • people and communities
  • environment
  • ethical business conduct

See Novartis Chairman Daniel Vasella, M.D., discuss the values and principles of the United Nations Global Compact on its 10th anniversary.

Daniel Vasella

UN honors Novartis Chairman

Novartis Chairman Daniel Vasella, M.D., was honored by the United Nations at the Global Compact Leaders Summit 2010 held in New York June 24-25. Dr. Vasella was recognized for early and sustained support of the Global Compact, which has become the world's most broadly accepted corporate citizenship initiative. In 2000 Novartis became one of the first signatories of the Global Compact. In a letter to Novartis associates, announcing the commitment and Dr. Vasella called the principles of the Global Compact “important building blocks for a free and prosperous world economy”.

Experience the global reach of Corporate Citizenship at Novartis in this slide show.